Thursday, April 15, 2010

R&D IT Best Practices for Growing Small/Mid-Sized Biopharmas

As smaller biopharma companies grow and mature into larger organizations, they need to transition from relatively ad hoc, spreadsheet heavy, lightly supported R&D IT environments to more comprehensive, scalable platforms and support models. This presents substantial challenges to scientists, managers, and IT professionals, ranging from prioritization of new features and functions, creation of new workflows, budget and staffing issues, in-house platforms versus COTS (commercial-off-the-shelf) platforms, and getting support for necessary changes. MassTLC's Life Sciences Cluster presented these issues and more during an interactive roundtable discussion.

Participants included Joseph Cerro of The Schooner Group as moderator, David Osterman, Director of Research Informatics at Biorelix, Tom Plasterer, Adjunct Professor at Northeastern University, Keith Robison, Lead Senior Scientist at Infinity Pharmaceuticals, Jeff Warhaft, Associate Director, R&D IT Solutions Delivery at Biogen Idec, Barry Wythoff, Scientist & IT Project Manager at Ironwood Pharmaceuticals, and David Yee, Head of Knowledge & Information Systems at Archemix Corporation.

No comments: